Generative adversarial network constrained multiple loss autoencoder: A deep learning‐based individual atrophy detection for Alzheimer's disease and mild cognitive impairment

Abstract

Exploring individual brain atrophy patterns is of great value in precision medicine for Alzheimer's disease (AD) and mild cognitive impairment (MCI). However, the current individual brain atrophy detection models are deficient. Here, we proposed a framework called generative adversarial network constrained multiple loss autoencoder (GANCMLAE) for precisely depicting individual atrophy patterns. The GANCMLAE model was trained using normal controls (NCs) from the Alzheimer's Disease Neuroimaging Initiative cohort, and the Xuanwu cohort was employed to validate the robustness of the model. The potential of the model for identifying different atrophy patterns of MCI subtypes was also assessed. Furthermore, the clinical application potential of the GANCMLAE model was investigated. The results showed that the model can achieve good image reconstruction performance on the structural similarity index measure (0.929 ± 0.003), peak signal‐to‐noise ratio (31.04 ± 0.09), and mean squared error (0.0014 ± 0.0001) with less latent loss in the Xuanwu cohort. The individual atrophy patterns extracted from this model are more precise in reflecting the clinical symptoms of MCI subtypes. The individual atrophy patterns exhibit a better discriminative power in identifying patients with AD and MCI from NCs than those of the t ‐test model, with areas under the receiver operating characteristic curve of 0.867 (95%: 0.837–0.897) and 0.752 (95%: 0.71–0.790), respectively. Similar findings are also reported in the AD and MCI subgroups. In conclusion, the GANCMLAE model can serve as an effective tool for individualised atrophy detection.

Nomograms for Predicting the Risk and Prognosis of Liver Metastases in Pancreatic Cancer: A Population-Based Analysis

“…Deep learning evolved from the study of artificial neural networks; however, it is not identical to conventional neural networks. Nevertheless, in terms of vocabulary, the many deep learning algorithms, including deep reinforcement learning, generative adversarial networks, recurrent neural networks, and convolutional neural networks, use the phrase “neural network” [ 47 , 48 , 49 , 50 ]. Deep learning can be thought of as a semi-theoretical, semi-empirical modelling approach that employs human understanding of mathematics and computer algorithms, along with as much training information as is possible, to construct an architectural framework, utilizing the massive computing power of computers to tune the internal criteria to approximate the issue’s objectives as closely as possible [ 51 ].…”

A novel spatiotemporal graph convolutional network framework for functional connectivity biomarkers identification of Alzheimer’s disease

“…APOE ε4 and Aβ information was also collected from the participants. The inclusion criteria for cohort II data were previously reported [ 30 ], and the entry criteria for CN individuals [ 29 ] and the diagnostic criteria for AD dementia [ 31 ] and MCI [ 32 ] were in accordance with established guidelines. Please refer to the supplementary material (Participants: Cohort II) for more details.…”

Evaluation of pseudo-healthy image reconstruction for anomaly detection with deep generative models: Application to brain FDG PET

“…Based on the fundamental work of Schlegl et al (2017) who introduced AnoGAN and its improved version, the f-AnoGAN (Schlegl et al, 2019), several frameworks using GANs have been developed, for instance VAE-GAN (Baur et al, 2019), ANT-GAN (Sun et al, 2020), or cycleGAN (Xia et al, 2019(Xia et al, , 2020. More recently, Shi et al (2023) introduced GANCMLAE, a GAN-based approach combined with an autoencoder and constrained by multiple losses for the early detection of brain atrophy. Another novel and interesting approach has been proposed by Siddiquee et al (2023), who train a GAN-based model with both healthy and abnormal images to have a fully unsupervised method.…”